Mitolyn is a newly introduced weight management supplement that claims to unlock the body’s metabolic potential. According to ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20 ... “Zepbound promotes weight loss and has been shown to reduce ...

And as of December 20, Eli Lilly’s weight loss drug Zepbound (tirzepetide) has become the first prescription medication FDA-approved to treat obstructive sleep apnea by increasing airflow and ...

The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...

called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.Although the new FDA green light doesn't expand the ...